Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Veras, Flavio P ^a   Peres, Raphael S ^a   Saraiva, Andre L L ^a   Pinto, Larissa G ^a   Louzada Junior, Paulo ^a   Cunha, Thiago M ^a   Paschoal, Jonas A R ^a   Cunha, Fernando Q ^a   Alves Filho, Jose C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ANTIINFLAMMATORY AGENT; APYRASE; CD39 ANTIGEN; CYTOKINE; FRUCTOSE BISPHOSPHATE; FRUCTOSE-1,6-DIPHOSPHATE; LEUKOCYTE ANTIGEN;

ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRITIS, EXPERIMENTAL; DISEASE MODEL; DRUG EFFECTS; EXTRACELLULAR SPACE; GLYCOLYSIS; MALE; METABOLISM; MOUSE; PATHOLOGY; RHEUMATIC FEVER; SIGNAL TRANSDUCTION;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; APYRASE; ARTHRITIS, EXPERIMENTAL; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; FRUCTOSEDIPHOSPHATES; GLYCOLYSIS; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; RECEPTOR, ADENOSINE A2A; RHEUMATIC FEVER; SIGNAL TRANSDUCTION;

EID: 84945208448     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15171     Document Type: Article

References (45)

1. McInnes, I. B., Schett, G. The Pathogenesis of Rheumatoid Arthritis. N. Engl. J. Med. 365, 2205-2219 (2011).
2. Rau, R., Herborn, G. Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin. Exp. Rheumatol. 22, S83-94 (2004).
3. Cronstein, B. N., Naime, D., Ostad, E. The antiinflammatory mechanism of methotrexate: Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92, 2675-2682 (1993).
4. Möttönen, T. et al. Comparison of combination therapy with single-drug therapy in e a rly rheumatoid arthritis : a randomised trial. Lancet 353, 1568-1573 (1999).
5. O'Dell, J. R. et al. Therapies for active rheumatoid arthritis after methotrexate failure. N. Engl. J. Med. 369, 307-18 (2013).
6. Jacobson, K. A., Gao, Z.-G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247-64 (2006).
7. Haskó, G., Cronstein, B. Regulation of inflammation by adenosine. Front. Immunol. 4, 85 (2013).
8. Dwyer, K. M. et al. CD39 and control of cellular immune responses. Purinergic Signal. 3, 171-80 (2007).
9. Antonioli, L., Pacher, P., Vizi, E. S., Haskó, G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19, 355-67 (2013).
10. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-65 (2007).
11. Kirtley, M. E., McKay, M. Fructose-1,6-bisphosphate, a regulator of metabolism. Mol. Cell. Biochem. 18, 141-149 (1977).
12. Planas, M. E., Sánchez, S., González, P., Rodrigues de Oliveira, J., Bartrons, R. Protective effect of fructose 1,6-bisphosphate against carrageenan-induced inflammation. Eur. J. Pharmacol. 237, 251-255 (1993).
13. Alves Filho, J. C. F., Santos, R. C. V., Castaman, T. A., de Oliveira, J. R. Anti-inflammatory effects of fructose-1,6-bisphosphate on carrageenan-induced pleurisy in rat. Pharmacol. Res. 49, 245-248 (2004).
14. Ahn, S. M. et al. Fructose-1,6-diphosphate attenuates prostaglandin E2 production and cyclo-oxygenase-2 expression in UVBirradiated HaCaT keratinocytes. Br. J. Pharmacol. 137, 497-503 (2002).
15. Sola, A., Panés, J., Xaus, C., Hotter, G. Fructose-1,6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine. J. Leukoc. Biol. 73, 74-81 (2003).
16. Frasnelli, M. E., Tarussio, D., Chobaz-péclat, V., Busso, N., So, A. TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Res. Ther. 7, 370-379 (2005).
17. Asquith, D. L., Miller, A. M., McInnes, I. B., Liew, F. Y. Animal models of rheumatoid arthritis. Eur. J. Immunol. 39, 2040-2044 (2009).
18. Cross, M., Mangelsdorf, I., Wedel, A & Renkawitz, R. Mouse lysozyme M gene: isolation, characterization, and expression studies. Proc. Natl. Acad. Sci. USA 85, 6232-6236 (1988).
19. Pinto, L. G. et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 148, 247-256 (2010).
20. Valério, D. et al. Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors. Br. J. Pharmacol. 158, 558-68 (2009).
21. Csóka, B. et al. A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 110, 2685-95 (2007).
22. Huang, S., Apasov, S., Koshiba, M., Sitkovsky, M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosinemediated inhibition of T-cell activation and expansion. Blood 90, 1600-10 (1997).
23. Flögel, U. et al. Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis. Sci. Transl. Med. 4, 146ra108 (2012).
24. Mazzon, E. et al. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. J. Rheumatol. 38, 2119-29 (2011).
25. Peres, R. S. et al. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 112, 2509-14 (2015).
26. Montesinos, M. C., Desai, A., Cronstein, B. N. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. Arthritis Res. Ther. 8, R53 (2006).
27. Eltzschig, H. K., Sitkovsky, M. V & Robson, S. C. Purinergic signaling during inflammation. N. Engl. J. Med. 367, 2322-33 (2012).
28. Ehringer, W. D. et al. Membrane permeability of fructose-1,6-diphosphate in lipid vesicles and endothelial cells. Mol. Cell. Biochem. 210, 35-45 (2000).
29. Ehringer, W. D., Su, S., Chiangb, B., Stillwell, W., Chien, S. Destabilizing effects of fructose-1,6-bisphosphate on membrane bilayers. Lipids 37, 885-92 (2002).
30. Gregory, G. A., Welsh, F. A., Yu, A. C., Chan, P. H. Fructose-1,6-bisphosphate reduces ATP loss from hypoxic astrocytes. Brain Res. 516, 310-2 (1990).
31. Markov, A. K., Oglethorpe, N., Terry, J., Grogan, J. B., Hellems, H. K. Stimulating effect of fructose 1-6 diphosphate on the phagocytic function of rat RES and on human leukocyte carbohydrate metabolism. Am. J. Med. Sci. 290, 3-10 (1985).
32. Markov, A. K., Oglethorpe, N. C., Blake, T. M., Lehan, P. H., Hellems, H. K. Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am. Heart J. 100, 639-646 (1980).
33. Hassinen, I. E. et al. Mechanism of the effect of exogenous fructose 1,6-bisphosphate on myocardial energy metabolism. Circulation 83, 584-593 (1991).
34. Farias, L. A., Smith, E. E., Markov, A. K. Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate. Stroke. 21, 606-613 (1990).
35. Zhang, J. N., Zhang, F. M., Ma, W. S., Forrester, T. Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock. Cardiovasc. Res. 22, 927-932 (1988).
36. Chrobak, P. et al. CD73 Plays a Protective Role in Collagen-Induced Arthritis. J. Immunol. 194, 2487-2492 (2015).
37. Anastasiou, D. et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8, 839-47 (2012).
38. Morgan, H. P. et al. M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc. Natl. Acad. Sci. USA 110, 5881-6 (2013).
39. Yang, L. et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 5, 4436 (2014).
40. Palsson-McDermott, E. M. et al. Pyruvate Kinase M2 Regulates Hif-1? Activity and IL-1? Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages. Cell Metab. 21, 65-80 (2015).
41. Vexler, Z. et al. Toxicity of fructose-1,6-bisphosphate in developing normoxic rats. Pharmacol. Toxicol. 84, 115-121 (1999).
42. Nunes, F. B. et al. Intravenous toxicity of fructose-1,6-bisphosphate in rats. Toxicol. Lett. 143, 73-81 (2003).
43. Faust, N., Varas, F., Kelly, L. M., Heck, S., Graf, T. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96, 719-726 (2000).
44. Grespan, R. et al. CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. Arthritis Rheum. 58, 2030-2040 (2008).
45. Zhang, Y. et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat. Med. 17, 79-86 (2011).